Endo Revenue 2006-2018 | ENDP

Endo revenue from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Endo Annual Revenue
(Millions of US $)
2018 $2,947
2017 $3,469
2016 $4,010
2015 $3,269
2014 $2,381
2013 $2,125
2012 $2,816
2011 $2,525
2010 $1,716
2009 $1,461
2008 $1,261
2007 $1,086
2006 $910
2005 $820
Endo Quarterly Revenue
(Millions of US $)
Q4 2018 $786
Q3 2018 $745
Q2 2018 $715
Q1 2018 $701
Q4 2017 $769
Q3 2017 $787
Q2 2017 $876
Q1 2017 $1,038
Q4 2016 $1,242
Q3 2016 $884
Q2 2016 $921
Q1 2016 $964
Q4 2015 $1,074
Q3 2015 $746
Q2 2015 $735
Q1 2015 $714
Q4 2014 $663
Q3 2014 $654
Q2 2014 $593
Q1 2014 $471
Q4 2013 $93
Q3 2013 $661
Q2 2013 $712
Q1 2013 $658
Q4 2012 $589
Q3 2012 $750
Q2 2012 $785
Q1 2012 $691
Q4 2011 $598
Q3 2011 $759
Q2 2011 $608
Q1 2011 $560
Q4 2010 $511
Q3 2010 $444
Q2 2010 $397
Q1 2010 $364
Q4 2009 $391
Q3 2009 $361
Q2 2009 $373
Q1 2009 $335
Q4 2008 $347
Q3 2008 $317
Q2 2008 $306
Q1 2008 $290
Q4 2007 $305
Q3 2007 $269
Q2 2007 $257
Q1 2007 $254
Q4 2006 $259
Q3 2006 $217
Q2 2006 $228
Q1 2006 $205
Q4 2005 $241
Q3 2005 $245
Q2 2005 $196
Q1 2005 $138
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.869B $2.947B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.886B 31.19
Takeda Pharmaceutical (TAK) Japan $32.716B 12.10
Grifols (GRFS) Spain $12.878B 15.61
Ionis Pharmaceuticals (IONS) United States $10.920B 33.86
Jazz Pharmaceuticals (JAZZ) Ireland $7.794B 11.16
Neurocrine Biosciences (NBIX) United States $7.730B 500.65
Sage Therapeutics (SAGE) United States $7.380B 0.00
Tilray (TLRY) United States $6.257B 0.00
Catalent (CTLT) United States $5.923B 24.80
Nektar Therapeutics (NKTR) United States $5.601B 8.94
United Therapeutics (UTHR) United States $5.282B 8.98
FibroGen (FGEN) United States $4.533B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.247B 13.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.197B 22.30
Zogenix (ZGNX) United States $2.223B 0.00
PTC Therapeutics (PTCT) United States $2.194B 0.00
Portola Pharmaceuticals (PTLA) United States $2.136B 0.00
Aerie Pharmaceuticals (AERI) United States $2.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.106B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.070B 0.00
USANA Health Sciences (USNA) United States $2.010B 16.87
Heron Therapeutics (HRTX) United States $1.859B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.855B 23.10
Xencor (XNCR) United States $1.685B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.674B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.576B 136.50
Corcept Therapeutics (CORT) United States $1.281B 18.62
Theravance Biopharma (TBPH) Cayman Islands $1.280B 0.00
TherapeuticsMD (TXMD) United States $1.252B 0.00
Esperion Therapeutics (ESPR) United States $1.110B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.063B 0.00
Tricida (TCDA) United States $1.009B 0.00
Radius Health (RDUS) United States $0.866B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.813B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.591B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.569B 0.00
Odonate Therapeutics (ODT) United States $0.560B 0.00
GlycoMimetics (GLYC) United States $0.560B 0.00
ChemoCentryx (CCXI) United States $0.551B 0.00
Dermira (DERM) United States $0.550B 0.00
Collegium Pharmaceutical (COLL) United States $0.527B 0.00
ArQule (ARQL) United States $0.525B 0.00
Forty Seven (FTSV) United States $0.508B 0.00
KalVista Pharmaceuticals (KALV) United States $0.486B 0.00
Akebia Therapeutics (AKBA) United States $0.479B 0.00
Flexion Therapeutics (FLXN) United States $0.475B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.473B 27.90
Siga Technologies (SIGA) United States $0.466B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.413B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.410B 0.00
TCR2 THERAPTCS (TCRR) United States $0.407B 0.00
Translate Bio (TBIO) United States $0.404B 0.00
Aptorum Group (APM) China $0.381B 0.00
OptiNose (OPTN) United States $0.379B 0.00
Concert Pharmaceuticals (CNCE) United States $0.365B 0.00
ImmunoGen (IMGN) United States $0.360B 0.00
Karyopharm Therapeutics (KPTI) United States $0.331B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.313B 11.60
Verrica Pharmaceuticals (VRCA) United States $0.297B 0.00
CASI Pharmaceuticals (CASI) United States $0.296B 0.00
Minerva Neurosciences (NERV) United States $0.296B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
Mast Therapeutics (SVRA) United States $0.278B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.272B 0.00
Xeris Pharmaceuticals (XERS) United States $0.268B 0.00
Majesco Entertainment (PTE) United States $0.266B 0.00
Aclaris Therapeutics (ACRS) United States $0.253B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.249B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.249B 0.00
HARPOON THERAPT (HARP) United States $0.249B 0.00
Dova Pharmaceuticals (DOVA) United States $0.248B 0.00
ElectroCore (ECOR) United States $0.239B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
Recro Pharma (REPH) United States $0.213B 0.00
Tyme Technologies (TYME) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.202B 0.00
Molecular Templates (MTEM) United States $0.199B 0.00
Jounce Therapeutics (JNCE) United States $0.198B 0.00
Aldeyra Therapeutics (ALDX) United States $0.196B 0.00
Rafael Holdings (RFL) United States $0.193B 0.00
Redhill Biopharma (RDHL) Israel $0.186B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
IMV INC (IMV) Canada $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.180B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 182.20
Ocular Therapeutix (OCUL) United States $0.169B 0.00
Neos Therapeutics (NEOS) United States $0.163B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.155B 0.00
Neon Therapeutics (NTGN) United States $0.151B 0.00
AgeX Therapeutics (AGE) United States $0.147B 0.00
MediWound (MDWD) Israel $0.140B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
China SXT Pharmaceuticals (SXTC) China $0.138B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.127B 0.00
Cardiome Pharma (CORV) Canada $0.123B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
DURECT (DRRX) United States $0.113B 0.00
Zafgen (ZFGN) United States $0.106B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.106B 0.00
Adherex Technologies (FENC) United States $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.101B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
Infinity Pharmaceuticals (INFI) United States $0.100B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Avenue Therapeutics (ATXI) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.088B 0.00
India Globalization Capital (IGC) United States $0.087B 0.00
Otonomy (OTIC) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.082B 8.06
SCYNEXIS (SCYX) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.075B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.066B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.066B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.063B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.060B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Bio-Path Holdings (BPTH) United States $0.055B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.055B 0.00
KemPharm (KMPH) United States $0.053B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Capnia (SLNO) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.050B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.048B 0.00
Melinta Therapeutics (MLNT) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
NOVAN INC (NOVN) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
ContraFect (CFRX) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Achaogen (AKAO) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.025B 0.00
Shineco (TYHT) China $0.025B 4.23
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Pain Therapeutics (PTIE) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
VAXART, INC (VXRT) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00